Kuan‐lin Huang
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 11
- Modeling and Simulation top 5%
-
- Cancer Immunotherapy and Biomarkers 4
-
- DNA Repair Mechanisms 4
- Epigenetics and DNA Methylation 4
-
- Genomics and Rare Diseases 4
- BRCA gene mutations in cancer 4
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Hsin‐I HsiaoLi DingEric Ávila-ValesTomi JunTimothy J. O’DonnellBenjamin D. GreenbaumCaitlin CarrChristopher B. McClain
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Kuan‐lin Huang
48 papers receiving 767 citations
Peers
Comparison fields: 5 of 121
- Cancer Research 168
- Modeling and Simulation 50
- Oncology 171
- Molecular Biology 315
- Immunology 86
Countries citing papers authored by Kuan‐lin Huang
This map shows the geographic impact of Kuan‐lin Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuan‐lin Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuan‐lin Huang more than expected).
Fields of papers citing papers by Kuan‐lin Huang
This network shows the impact of papers produced by Kuan‐lin Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuan‐lin Huang. The network helps show where Kuan‐lin Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kuan‐lin Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 13 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 9 | |
| 13 | 2021 | 7 | |
| 14 | 2021 | 4 | |
| 15 | 2021 | 14 | |
| 16 | 2021 | 26 | |
| 17 | 2020 | 2 | |
| 18 | 2020 | 34 | |
| 19 | 2016 | 12 | |
| 20 | 2013 | 50 |
About Kuan‐lin Huang
Kuan‐lin Huang is a scholar working on Cancer Research, Aging and Modeling and Simulation, having authored 50 papers that have together received 777 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (11 papers), Genomics and Rare Diseases (4 papers), DNA Repair Mechanisms (4 papers), BRCA gene mutations in cancer (4 papers), COVID-19 Clinical Research Studies (4 papers), Epigenetics and DNA Methylation (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Cancer Research (168 citations), Modeling and Simulation (50 citations) and Oncology (171 citations). Kuan‐lin Huang has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Hsin‐I Hsiao, Li Ding, Eric Ávila-Vales, Tomi Jun, Timothy J. O’Donnell, Benjamin D. Greenbaum, Caitlin Carr, Christopher B. McClain, Robert Samstein and Theofano Orfanelli. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.